Tekmira Achieves $1.5 Million Development Milestone
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/3/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
- AXT-Tongmei signs 3-year wafer supply deal with Coherent
Tekmira Pharmaceuticals (TKMR) Reaches $1.5M Milestone in Monsanto (MON) Agreement
October 3, 2014 6:22 AM EDTTekmira Pharmaceuticals (Nasdaq: TKMR) announced that it has achieved a development milestone supporting a $1.5 million payment from Monsanto (NYSE: MON), following completion of specified program objectives. This work is part of the research program under the Option Agreement Tekmira signed... More
